Rhythm Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
02.03.26
/
50%
€81.50
Target price
02.03.27
€118.79
Performance (%)
-1.84%
Price
08.05.26
€80.00
Summary
This prediction is currently active. With a performance of -1.84%, the BUY prediction by Canaccord_Genuity_Gr is trending in the wrong direction. This prediction currently runs until 02.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 15.942% | 15.942% |
| iShares Core DAX® | 0.224% | 1.805% |
| iShares Nasdaq 100 | 6.047% | 15.716% |
| iShares Nikkei 225® | 5.724% | 12.343% |
| iShares S&P 500 | 2.172% | 7.723% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Canaccord Genuity Group Inc. from $141.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.03.23
02.03.23
€52.93
02.03.24
02.03.24
85.85%
03.03.24
03.03.24
